Cooley Shortlisted in Multiple Categories for 2022 LMG Life Sciences EMEA Awards

London – April 08, 2022 – Cooley has been shortlisted in five practice categories of the 2022 LMG Life Sciences EMEA Awards: UK Firm of the Year; Licensing & Collaboration Firm of the Year; Opposition Procedure Firm of the Year; Patent Litigation Firm of the Year: Biotech; and Venture Capital Firm of the Year.

Additionally, the publication noted five Cooley lawyers as finalists for awards: Nicola Maguire and John Wilkinson for Licensing & Collaboration Lawyer of the Year; Michal Berkner for M&A Lawyer of the Year; Tanya Heare-Rowlands for Patent Litigator of the Year: Biotech; and Tom Goodman for Corporate Rising Star.

View the full shortlist

The winners will be announced at a ceremony in London on May 12, 2022.

LMG Life Sciences produces one of the most respected awards programs for life sciences practitioners and firms in the United States, Canada, Europe, the Middle East and Africa. Winners are determined through a rigorous research process that aims to survey excellent legal service over a 12-month period. Covered in the award categories are four key practice areas: financial & corporate, regulatory, intellectual property, and non-IP litigation & enforcement.

Cooley is a top law firm for emerging and mature life sciences companies, and counsels 1,900+ public and private life sciences company clients worldwide, including nearly 50% of the Nasdaq Biotechnology Index. The firm advises on all aspects of life sciences technologies for established public companies and growing startups. Cooley has been the #1 VC law firm for biotech and pharma venture financings for the past decade and is the #1 firm for issuer-side life sciences IPOs – a title held since 2000.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 1,500 lawyers across 17 offices in the United States, Asia and Europe.